PRIVACY NOTICE TO PARTICIPANTS: Immunization of women with diphtheria and tetanus toxoids combined with acellular pertussis (Tdap) during the mid third trimester of pregnancy: an evaluation of the potential for immunological protection for the neonate

Privacy Notice for volunteers who participated in the clinical trial entitled: Immunization of women with diphtheria and tetanus toxoids combined with acellular pertussis (Tdap) during the mid third trimester of pregnancy: an evaluation of the potential for immunological protection for the neonate

We wish to inform you that anonymized data from the above-mentioned clinical trial will be transferred to the vaccine manufacturer Sanofi Pasteur for the sole purpose of submission to international Health Authorities as part of vaccine registration procedures. This data transfer has been approved by the IWK Research Ethics Board. Should you have any question, please contact Darlene MacAulay at darlene.macaulay@iwk.nshealth.ca